produced three DNA adducts that were inhibited by the addition of either ascorbic acid or glutathione, by 66 and 90%, respectively. The DNA adducts formed in HL-60 cells treated with eugenol were the same as those formed by in vitro peroxidase activation. In addition to adduct formation, peroxidase activation of eugenol produced a 2-to 3-fold increase in the level of oxidative base damage. Eugenol quinone methide was prepared by Ag(I)oxide oxidation of eugenol. Peroxidase activation of eugenol gave a product that had the same UV spectrum as eugenol quinone methide, which suggests that it was one of the products. Reaction of eugenol quinone methide with either DNA or deoxyguanosine-3Ј-phosphate produced two principal adducts (2 and 4). When DNA adduct 2 formed by incubation of eugenol quinone methide with deoxyguanosine-3Ј-phosphate was compared with DNA 2 adduct formed in HL-60 cells treated with eugenol results demonstrated that they were the same. This suggests that eugenol quinone methide is one of the reactive intermediates leading to DNA adduct formation in cells. Activation of eugenol with 10 µM copper sulfate resulted in the production of one principal (2) and several minor adducts. DNA adduct 2 formed by activation of eugenol with copper sulfate was the same as DNA adduct 2 formed by either peroxidase activation of eugenol or by reactions with eugenol quinone methide, which indicates that the reactive intermediates generated by these activation systems were similar. Copper sulfate produced a 95-fold increase in the level of oxidative base damage, which was significantly inhibited by the addition of either bathocuproinedisulphonic acid or cata-*Abbreviations: eugenol, 4-allyl-2-methoxyphenol; eugenol (QM), eugenol quinone methide; U, units; HRP, horseradish peroxidase; MPO, myeloperoxidase; dGp, 2Ј-deoxyguanosine 3Ј monophosphate; AA, ascorbic acid; GSH, reduced glutathione; BCS, bathocuproinedisulphonic acid; 8-OH-dG, 8-hydroxy-2-deoxyguanosine; EIMS, electron impact mass spectrometry; 1 H NMR, 1 H nuclear magnetic resonance; HPLC-EC, high performance liquid chromatography with electrochemical detection; PEI, polyethylenimine; RAL, relative adduct level.
Introduction
Eugenol (4-allyl-2-methoxy phenol*) is a naturally occurring compound that has been used extensively as a flavoring agent and fragrance. Human exposure to eugenol also occurs through its use as an analgesic and from clove cigarettes (1, 2) . Compared with related allylbenzenes derivatives such as safrole and estragole, which are hepato-carcinogenic in mouse models (3), eugenol has not shown similar evidence for carcinogenicity (4) . However, pulmonary toxicity has been associated with eugenol exposure (2, 5, 6) .
Liver microsomal activation systems have been used to study the activation of eugenol (7, 8) . These studies have demonstrated that eugenol can be oxidized to intermediate(s) that react with microsomal proteins and reduced glutathione (GSH) to form adducts (7, 8) . The conclusion from these studies and related studies have been that eugenol is converted to a quinone methide derivative to form the adducts detected (7) (8) (9) (10) (11) .
Our laboratory has been interested in the extrahepatic oxidation of aromatic compounds to form DNA adducts. The extensive distribution in extrahepatic tissues of peroxidase enzymes, such as myeloperoxidase, uterine peroxidase, lactoperoxidase and tyrosinase or enzymes with peroxidative activities such as prostaglandin H-synthase (12) (13) (14) , have lead us to investigate the activation of phenolic compounds with peroxidase enzymes (15) . In many cases, the phenolic metabolites of aromatic compounds can be further oxidized by peroxidase enzymes to form DNA adducts. For example, the benzene metabolites, hydroquinone, catechol and 1,2,4-benzenetriol, are activated by myeloperoxidase containing HL-60 cells to form DNA adducts (16) (17) (18) . Similarly, treatment of these cells with o-phenyl hydroquinone, a metabolite of o-phenyl phenol, results in DNA adduct formation (19) .
As a cellular model for peroxidative activation, we have employed HL-60 cells (16) (17) (18) (19) . Comparative analyses have demonstrated that the DNA adducts formed in HL-60 cells treated with benzene metabolites are the same as those formed in either human bone marrow treated in vitro or in mice administered benzene (18, 20) . These results have suggested to us that HL-60 cells are a very good model system to investigate the peroxidase mediated activation of phenolic compounds. In addition to peroxidase enzymes, transition metals present in tissues may contribute to the oxidation of phenolic compounds (21, 22) . A Cu 2ϩ /Cu ϩ redox activation mechanism has been demonstrated to oxidize a variety of compounds to produce DNA strand breaks (23) (24) (25) . The intermediate(s) generated by phenolic compounds acting as reducing co-substrates for peroxidase enzymes may be the same as those formed during Cu 2ϩ /Cu ϩ redox activation.
In most cases, the reactive intermediates of phenolic compounds leading to adduct formation remain to be defined. The fully oxidized quinone derivatives of these compounds can react directly with DNA to form DNA adducts (19, 26, 27) . Recent studies have demonstrated that the quinone methide derivatives of two tamoxifen metabolites can react with DNA to form DNA adducts (28, 29) . Although, evidence for the reaction of eugenol quinone methide with GSH has been presented (7, 11) , no evidence on the formation of DNA adducts by this reactive intermediate have been reported to date.
During the oxidation of phenolic compounds, a variety of reactive oxygen species may also be generated (30) . These reactive oxygen species including superoxide, hydroxy radicals and singlet oxygen, lead to the formation of a wide variety of base oxidation products. 8-Hydroxy-2Ј-deoxyguanosine (8-OH-dG) is one of the identified products of oxidative base damage and it has been used as an indicator of oxidative base damage (31) .
In these studies, we have taken a multifaceted approach to analyze the activation of eugenol to form DNA damage. We have used horseradish peroxidase, myeloperoxidase, CuSO 4 and HL-60 cells to study DNA adduct and 8-OH-dG formation by eugenol. The DNA adducts formed by these activation systems were compared with the DNA adducts formed by eugenol (QM). These studies demonstrate that activation of eugenol leads to the formation of both DNA adducts and 8-OH-dG and that quinone methide derivative contributes to the formation of DNA adducts in HL-60 cells.
Materials and methods

Chemicals
Calf thymus DNA, horseradish peroxidase (HRP) (Type VI), myeloperoxidase (MPO), H 2 O 2 , catalase and mannitol were purchased from Sigma Chemical Co. (St Louis, MO). Eugenol and bathocuproinedisulphonic acid (BCS) were obtained from Aldrich Chemical Co. (Milwaukee, WI). All other chemicals were of the highest analytical grade available.
Instrumentation EIMS was performed with a VG70-SE mass spectrometer (VG Analytical Ltd, Manchester, England) at an ionizing voltage of 70 V and a accelerating voltage of 5 kV. 1 H-NMR spectra were recorded with a 300 MHz QE-300 spectrometer (General Electric, Fremont, CA). UV spectra were recorded with a Shimadzu 2101 spectrophotometer (Columbia, MD)
Synthesis of eugenol quinone methide (QM)
Eugenol quinone methide (QM) was prepared according to published procedures (32) . Briefly, 17 mg of eugenol was dissolved in 10 ml of acetonitrile and heated to 60°C. An aliquot of 700 mg of Ag(I)O was added and the solution was stirred vigorously for 30 min. After filtration, the product was dissolved in deuterochloroform. Tetramethylsilane was used as an internal standard and the product was characterized by 1 H NMR and mass spectrometry (EIMS M ϩ m/z 162).
Treatment of HL-60 cells
HL-60 cells were cultured as previously described (16) (17) (18) (19) . The cultures were incubated at 37°C in a humidified 5% CO 2 /95% air atmosphere. Eugenol was dissolved in DMSO and added to the cultures for 24 h. To some of the flasks was added the combination of 100 µM eugenol and 100 µM H 2 O 2 . Following treatment, the cells were collected by centrifugation and resuspended in cold Hanks balanced salt solution. The cells were collected by centrifugation and the cell pellets were stored at -70°C until the DNA was isolated by a modified Marmur procedure (33) .
Activation of eugenol by peroxidase enzymes
The incubation mixture consisted of 500 µg of purified calf thymus DNA, 100 µM eugenol, either 15 U HRP or 0.5 U MPO and 100 µM H 2 O 2 in 10 mM KH 2 PO 4 , pH 7.5. The final volumes of the incubations were 2 ml. To 438 some of the incubations, either 500 µM of ascorbic acid (AA) or reduced glutathione (GSH) was also added. The mixtures were incubated in a water bath at 37°C for 2 h. The reactions were stopped with the addition of 1 ml ice-cold chloroform and were extracted five times with chloroform:isoamyl alcohol (24:1) and water saturated ethylacetate. The DNA was precipitated with 4 M sodium acetate and cold ethanol, and dissolved in 1 mM sodium chloride and 1.5 mM sodium acetate. Activation of eugenol by CuSO 4 The reaction mixtures contained 500 µg DNA, 100 µM eugenol and 10 µM copper sulfate (CuSO 4 ) in 10 mM phosphate buffer, pH 7.4. The final volumes of the mixtures were adjusted to 2 ml. Control incubations were carried out in the absence of either CuSO 4 , or eugenol. To some of the reactions either 150 U catalase, 100 µM BCS, or 100 mM mannitol was also added. The mixtures were incubated for 2 h at 37°C followed by several extractions with chloroform:isoamyl alcohol. The DNA was precipitated with sodium acetate and ethanol and washed three times with 70% ethanol. The DNA samples were dissolved in 1 mM sodium chloride and 1.5 mM sodium acetate and stored at -20°C. DNA concentration was determined using a modified diphenylamine assay (34) .
Incubation of eugenol (QM) with DNA or 3Ј-dGp
An aliquot of 1 mg of freshly prepared eugenol (QM) was incubated with either 1 mg DNA or 1 mg dGp in 10 mM KH 2 PO 4 , pH 7 in a reaction volume of 2 ml. The reactions were carried out for 2 h at 37°C. DNA was extracted and precipitated as described above. Aliquots of the reactions with dGp were used directly.
P-Post-labeling analysis of adducts
The P 1 nuclease enhanced 32 P-post-labeling was performed using 4 µg of purified DNA as previously described (16-18 In the D 0 solvent, the plates were developed from the bottom to~16 cm onto a paper wick. In D 1 , the plates were developed from the bottom to the top of the plate. In the D 2 and D 3 solvents they were developed at a right angle to the previous direction of development to~5 cm onto a paper wick. The adducts were located by autoradiography using Kodak XAR-5 film and a DuPont Chronex Lightning Plus intensifying screen. The areas corresponding to adducts were scraped into scintillation vials containing 5 ml of scintillation cocktail (Safety Solve, Research Products Inc., Mount Prospect, IL) and the radioactivity was determined by scintillation counting. Areas adjacent to the radioactive spots were also scraped and counted for the determination of the background radioactivity. The relative adduct levels (RAL) were calculated as previously described (16) (17) (18) . Rechromatography analysis of adducts Individual adducts were eluted from PEI-cellulose with intermittent shaking using 0.5 ml 1.5 triethylammonium bicarbonate (pH 7.5). The eluted material was evaporated to dryness and redissolved in 10 µl of water. Aliquots of the samples were applied to PEI-cellulose sheets both individually and as mixtures. The plates were developed in one dimension using either 1.8 M lithium formate and 4.5 M urea (pH 3.5) or 1.7 M sodium phosphate (pH 6.0).
HPLC-EC measurement 8-OH-dG
Aliquots of~50-100 µg calf thymus DNA in 20 mM sodium acetate, 0.2 mM ZnCl 2 , pH 4.8, was hydrolyzed to nucleotides by 15 U nuclease P1 incubated at 70°C for 15 min (35) . The pH of the solution was adjusted by the addition of 1 M Tris-HCl, pH 7. Alkaline phosphatase (2 U) was added and the incubation was continued at 37°C for 1 h. The hydrolysate was filtered through a 0.2 µm microfilter (Bioanalytical Systems Inc., West Lafayette, IN) and analyzed on HPLC with an Alltech 5 µm C-18 reversed phase analytical column (250ϫ4.6 mm) eluted with 10% methanol in 50 mM sodium phosphate buffer, pH 5.5. The HPLC system consisted of a model 250 Perkin-Elmer solvent delivery system coupled to a Coulochem II electrochemical detector with a model 5010 analytical cell ESA (Chelmsford, MA). Electrochemical response was digitized with a Nelson interface and analyzed using TurboChrom 4 (Perkin-Elmer Inc., Cupertino, CA). The electrochemical detector was set at ϩ100 mV (electrode 1) and ϩ400 mV (electrode 2). The 8-OH-dG standard was prepared as previously described (36) . Quantification of 8-OH-dG in the samples was carried out by comparison with a calibration curve of 0.2 to 8 pmol 8-OH-dG prepared daily.
Results
In HL-60 cells treated with DMSO alone, no DNA adducts were detected by 32 P-post-labeling ( Figure 1A) . Treatment of HL-60 cells with 100 µM eugenol for 24 h produced three DNA adducts with an average RAL of 0.5ϫ10 -7 ( Figure 1B) . The same DNA adducts were detected after treatment with 1000 µM eugenol ( Figure 1C ). The average relative distribution of adducts 1, 2 and 3 were 44.7%, 18.2% and 37.1%, respectively. The level of DNA adducts formed in HL-60 cells was significantly correlated with the treatment concentration (R 2 ϭ 0.99, Table I ). Compared with treatment with 100 µM eugenol alone, the combination of 100 µM eugenol and 100 µM H 2 O 2 potentiated the level of DNA adducts formed in HL-60 cells by 14-fold (Table I ) and produced an adduct profile similar to that observed after treatment with 1000 µM eugenol ( Figure 1D ). Treatment with 100 µM H 2 O 2 alone did not produce DNA adducts that were detected under these postlabeling conditions. In the presence of DNA, in vitro activation of 100 µM eugenol with 15 U HRP and 100 µM H 2 O 2 produced 3 DNA adducts (Figure 2A ). The RAL was 10.4 ϫ 10 -7 and the distribution of the adducts were 1 ϭ 49%; 2 ϭ 28% and 3 ϭ 23%. In reactions not containing HRP and H 2 O 2 , no DNA adducts were observed. Activation of eugenol with 0.5 U of MPO and H 2 O 2 produced three DNA adducts with a RAL of 2.15 Ϯ 0.9ϫ10 -7 . The adducts detected were similar to those formed by HRP ( Figure 2B ). Addition of either 500 µM ascorbic acid (AA) or GSH to the activation system inhibited the formation of DNA adducts by 66% and 90%, respectively (Table II) . Incubation of 100 µM of eugenol with 10 µM CuSO 4 resulted in the production of one principal DNA adduct 2 and several minor adducts ( Figure 2C ) with a RAL of 2.86 Ϯ 0.8 ϫ 10 -7 . Eugenol (QM) was prepared by Ag(I)O oxidation of eugenol. The UV spectrum of the eugenol (QM) showed absorption maxima at 265 and 360 nm (Figure 3) , which are similar to reported values (9) . In the 1 H-NMR spectrum of eugenol (QM), the signals corresponding to the methoxy protons appeared as two singlets at 3.808 and 3.847 indicating the presence of both the cis and trans isomers (not shown). The EIMS spectrum of eugenol (QM) had a molecular ion at 162 m/z, which was consistent with the loss of two protons from eugenol (not shown). Fragments at 132.0 and 119.1 were consistent with the loss of the methoxy and allylic groups, respectively. Incubation of eugenol with HRP and 100 µM H 2 O 2 resulted in a significant shift in the UV absorption spectrum of eugenol ( Figure 3 ). After 2 min of incubation, the UV spectrum was similar to that of eugenol (QM) produced by chemical oxidation (Figure 3) .
Eugenol (QM) prepared by Ag(I)oxide oxidation of eugenol was incubated with DNA. 32 P-Post-labeling analysis of the products demonstrated the formation of two-principal adducts 2 and 4 ( Figure 4A ). Additional minor adducts were observed with longer exposure. The RAL produced by this reaction was 44.3 Ϯ 15.3 ϫ 10 -7 . Reactions of eugenol (QM) with dGp produced a similar adduct profile as observed in the reaction with DNA ( Figure 4B ). However, the RAL produced in this reaction was significantly higher 145.8 Ϯ 72.3 ϫ 10 -7 .
Rechromatography experiments were performed to compare the individual DNA adducts formed in HL-60 cells treated with eugenol with the DNA adducts formed by peroxidase activation of eugenol and with those formed by eugenol (QM) ( Figure 5 ). The result of this comparison demonstrates that DNA adducts 1, 2 and 3 formed in either HL-60 cells or the in vitro activation systems are the same ( Figure 5A , B and C). DNA adduct 2 formed in HL-60 cells treated with eugenol was the same as DNA adduct 2 formed by reaction of eugenol (QM) with dGp ( Figure 5D ). These same results presented in Figure 5A -D were also observed following chromatography in a different solvent system (not shown).
In addition to the formation of DNA adducts, peroxidase activation of eugenol in increased levels of 8-OH-dG. Incubation of eugenol with MPO and H 2 O 2 resulted in a 2-fold increase in the level of 8-OH-dG compared with the level of this oxidative base product in DNA incubated with eugenol and H 2 O 2 (Table III) . A 3-fold increase in the level of this product was obtained in the incubation with HRP plus H 2 O 2 . Inclusion of mannitol in the reaction mixture resulted in a 90% reduction in the level of 8-OH-dG.
Incubations of eugenol plus CuSO 4 significantly increased the formation of 8-OH-dG in DNA. In control samples, the level of 8-OH-dG was 0.12 pmol/µg DNA compared with 11.4 pmol/µg DNA in samples containing CuSO 4 (Table IV) . This represents a 95-fold increase in the level of 8-OH-dG. The formation of 8-OH-dG was modified by the addition of either metal ion chelators or free radical scavengers to the 440 Each of the incubations contained 100 µM of eugenol and 500 µg of DNA. To some of the incubations 15 U HRP, 0.5 U MPO, 100 µM H 2 O 2 and 100 mM mannitol were added as indicated. 8-OH-dG values are mean Ϯ standard deviation. reaction mixtures (Table IV) . The addition of BSC (a Cu ϩ -specific chelator) to the incubation, inhibited the formation of 8-OH-dG by 66%. The inclusion of either catalase or mannitol Activation system 8-OH-dG (pmol/µg DNA) (n ϭ 3)
DNA ϩ eugenol 0.12 Ϯ 0.05 DNA ϩ eugenol ϩ CuSO 4 11
All of the incubations contained 500 µg of DNA plus 100 µM of eugenol. To some of the reactions 10 µM CuSO 4 and either BCS, catalase or mannitol were added as indicated. 8-OH-dG values are mean Ϯ standard deviation.
in the reaction reduced the formation of oxidative base damage by 90%.
Discussion
We have used myeloperoxidase containing HL-60 cells to investigate the formation of DNA adducts by eugenol. Treatment of these cells with eugenol produced three DNA adducts, which were dependent upon treatment dose. At the concentrations investigated, the levels of DNA adducts formed in HL-60 after treatment with eugenol were similar to the levels of DNA adducts formed by treatment of these cells with a variety of agents including hydroquinone, catechol, 1,2,4-benzenetriol and o-phenyl-hydroquinone (16) (17) (18) (19) . The combination of eugenol plus H 2 O 2 potentiated the level of DNA adduct formation by 14-fold. This potentiation of DNA adducts is consistent with a cellular peroxidase dependent activation of eugenol to form DNA adducts and suggests that cellular peroxide levels are a limiting factor in this process. A similar potentiation of DNA adduct formation, by hydroquinone and catechol with the addition of H 2 O 2 to these cells, has been reported (37) .
In vitro activation of eugenol with either HRP or MPO plus H 2 O 2 lead to the formation of multiple DNA adducts. This peroxidase dependent formation of DNA adducts was significantly inhibited by the addition of either AA or GSH to the activation system. The Cu 2ϩ facilitated oxidation of eugenol was also found to produce DNA adducts. Previous studies of a variety of chemicals have demonstrated that this oxidation process leads to DNA strand breakage (23) (24) (25) ; however this is the first report of DNA adduct formation occurring. DNA adduct 2 produced by peroxidase activation was the principal adduct formed by CuSO 4 activation of eugenol. This similarity in adduct formation indicates that the reactive intermediate of eugenol leading to this adduct is produced by both of these activation systems.
Peroxidase activation of eugenol was investigated by UV spectroscopy. Incubation of eugenol with HRP and H 2 O 2 produced a time-dependent change in its UV absorption spectrum. After 2 min, the UV absorption spectrum was similar to that of eugenol (QM). We interpret these results to indicate that eugenol is a reducing co-substrate for compound I of HRP (38) . One electron reduction of compound I by eugenol would result in a eugenol semi-quinone intermediate. The formation of the detected quinone methide product may occur by a disproportionate mechanism (39) .
Reaction of eugenol (QM) with DNA produced two DNA adducts. Under the chromatography conditions used it was difficult to completely resolve these adducts. Investigation of 441 additional solvent systems were not successful in resolving these adducts. NMR analysis of eugenol (QM) suggested the presence of the cis and trans isomer. Therefore, the two adducts detected may correspond to different isomers; however this will require further investigation. Although evidence for the formation of adducts with liver microsomal proteins and GSH by eugenol (QM) have been presented in other studies (7, 11) , this is the first demonstration of DNA adduct formation by this intermediate. Reaction of eugenol (QM) with dGp produced a similar adduct profile as was observed in the DNA studies. This indicates that within DNA, dGp is the primary site for modification by eugenol (QM). DNA adduct 2 formed by eugenol (QM) was the same as DNA adduct 2 formed in HL-60 cells treated with eugenol. This demonstrates that eugenol (QM) is one of the reactive intermediates formed in HL-60 cells.
Activation of eugenol with either MPO or HRP also resulted in a 2-to 3-fold increase in the levels of oxidative base damage. This increase in the level of 8-OH-dG was inhibited by the addition of the hydroxyl radical scavenger mannitol, suggesting that generation of a trapable free radical was responsible for base oxidation. The redox activation of eugenol by Cu 2ϩ to produce 8-OH-dG DNA damage was investigated with the addition of chelating and radical scavenging agents to the incubation mixtures. BSC, a Cu ϩ -specific chelator (40) , inhibited the formation of 8-OH-dG by eugenol by 66%, which indicates a requirement for Cu ϩ in the production of oxidative base damage. The inclusion of catalase, which removes H 2 O 2 or the hydroxyl radical scavenger mannitol, significantly inhibited the formation of 8-OH-dG. Altogether, these results suggest a Fenton reaction mechanism for the increase in the levels of 8-OH-dG produced by CuSO 4 -facilitated oxidation of eugenol.
The peroxidase and Cu 2ϩ activation of eugenol to form DNA adducts and oxidative base damage can be described in a general model ( Figure 6 ) (23, 24, 41) . In this model, the reduced quinone, the semiquinone and the fully oxidized quinone methide forms of eugenol are indicated as QH 2 , QH • and QM, respectively. (42) . In this study, evidence for the formation of the eugenol (QM) in the HRP activation system was obtained by spectroscopic analysis of the products. Subsequent reduction of superoxide (O 2
•-) by Cu ϩ results in the production of H 2 O 2 (III).
As indicated in (IV) the formation of 8-OH-dG may proceed by a modified Fenton reaction (31) . This interpretation is supported by the inhibitory effects of both catalase and mannitol on the formation of 8-OH-dG. The significant inhibition of 8-OH-dG formation by mannitol suggests that the hydroxyl radical generated in (IV) is free to be trapped by this agent. However, in related studies with other agents, the radicals generated by Cu 2ϩ oxidation were not free in solution (25, (42) (43) (44) . A similar process to IV may also be responsible for the formation of 8-OH-dG during peroxidative activation of eugenol.
Our study demonstrated that eugenol (QM) (IIA and IIB) led to the formation of DNA adduct 2 in HL-60 cells treated with eugenol. The semiquinone (IA and IB) derivative of eugenol may be responsible for the formation of DNA adducts 1 and 3. The inhibition of adduct formation by AA and GSH may be caused either by reduction of the semiquinone to the parent compound or reaction with the quinone methide product. Studies have demonstrated trapping of eugenol (QM) products with GSH and this may be the process responsible for the observed inhibition of adduct formation observed in these studies (7, 11) .
Our studies demonstrate that activation of eugenol results in the formation of DNA adducts and oxidative base products. In vivo studies of DNA adduct formation by eugenol administration did not detect adduct formation in the liver (45) . In view of the effective inhibition of adduct formation by GSH, the lack of detectable adducts in the liver may be caused by the high levels of GSH present. However, we 442 propose that the formation of DNA adducts and oxidative base formation by peroxidative activation of eugenol may contribute to pulmonary toxicities that have been observed.
